2 research outputs found

    INDIVIDUAL APPROACH TO ULTRA LOSE DOSE REGIME OF MENOPAUSAL HORMONAL THERAPY IN PATIENTS AGED OVER 60

    Get PDF
    The menopausal hormonal therapy is represented today by ultra low doses in the form of drug Angeliq® Micro, which allows continuing MHT for patients older than 60-65  and choosing an individual MHT type
    corecore